Exploratory Data on the Clinical Efficacy of Monoclonal Antibodies against SARS-CoV-2 Omicron Variant of Concern

The MANTICO trial was a non-inferiority randomised controlled trial comparing the clinical efficacy of early treatments with bamlanivimab/etesevimab, casirivimab/imdevimab, and sotrovimab in outpatients aged 50 or older with mild-to-moderate SARS-CoV-2 infection.